The Critical Path Institute: transforming competitors into collaborators
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd4436.pdf
Reference5 articles.
1. Woodcock, J. & Woosley, R. The FDA Critical Path Initiative and its influence on new drug development. Annu. Rev. Med. 59, 1–12 (2008).
2. Rogers, J. A. et al. Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a beta regression meta-analysis. J. Pharmacokinet. Pharmacodyn. 39, 479–498 (2012).
3. Yu, P. et al. Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size. Neurobiol. Aging 35, 808–818 (2014).
4. Rudick, R. A. et al. Multiple Sclerosis Outcome Assessments Consortium: genesis and initial project plan. Mult. Scler. 20, 12–17 (2014).
5. Walker, E. G. et al. Evolving global regulatory science through the voluntary submission of data: a 2013 assessment. Ther. Innovation Regul. Sci. 48, 236–245 (2014).
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Regulatory agencies as innovation enablers: a conceptualization;Science and Public Policy;2024-08-13
2. The needs, challenges, and opportunities from the academic researchers' perspective;Essentials of Translational Pediatric Drug Development;2024
3. Challenges in Designing Clinical Trials to Test New Drugs in the Pregnant Woman and Fetus;Clinics in Perinatology;2019-06
4. Regulatory Science Objectives and Biomarker Qualification Through Public-Private Partnerships Are Critical to Delivering Innovative Treatments for CNS Diseases;Translational Medicine in CNS Drug Development;2019
5. New Frontiers in Parkinson's Disease: From Genetics to the Clinic;The Journal of Neuroscience;2018-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3